Your browser doesn't support javascript.
loading
Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial.
Guan, Jia-Lun; Hu, Yun-Lian; An, Ping; He, Qiong; Long, Hui; Zhou, Lin; Chen, Zhi-Fen; Xiong, Jian-Guang; Wu, Shi-Sheng; Ding, Xiang-Wu; Luo, He-Sheng; Li, Pei-Yuan.
Afiliación
  • Guan JL; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hu YL; Department of Gastroenterology, Hubei University of Chinese Medicine, Wuhan, China.
  • An P; Department of Gastroenterology, Wuhan University People's Hospital, Wuhan, China.
  • He Q; Department of Gastroenterology, Wuhan Red Cross Hospital, Wuhan, China.
  • Long H; Department of Gastroenterology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
  • Zhou L; Department of Gastroenterology, Suizhou Central Hospital, Wuhan, China.
  • Chen ZF; Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Xiong JG; Department of Gastroenterology, Xianning Central Hospital, Wuhan, China.
  • Wu SS; Department of Gastroenterology, The Second Hospital of Huangshi, Wuhan, China.
  • Ding XW; Department of Gastroenterology, Wuhan Puai Hospital, Wuhan, China.
  • Luo HS; Department of Gastroenterology, Wuhan University People's Hospital, Wuhan, China.
  • Li PY; Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pharmacotherapy ; 42(3): 224-232, 2022 03.
Article en En | MEDLINE | ID: mdl-35075679

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2022 Tipo del documento: Article País de afiliación: China